Jacobson Pharma Corporation Limited (HKG:2633)

HKG:2633 Income Statement

Financials in millions HKD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	1,577	1,468	1,268	1,596	1,446
Revenue Growth (YoY)	7.43%	15.79%	-20.55%	10.35%	-7.99%
Cost of Revenue	883.96	847.32	728.68	975.02	884.83
Gross Profit	692.94	620.48	538.92	620.52	561.08
Selling, General & Admin	324.24	332.38	297.92	397.63	407.59
Other Operating Expenses	-64.17	-23.31	-28.27	-25.58	-10.83
Operating Expenses	260.07	309.07	269.65	372.06	396.76
Operating Income	432.87	311.4	269.27	248.47	164.33
Interest Expense	-41.37	-78.71	-61.41	-25.69	-30.14
Interest & Investment Income	16.69	27.68	17.88	3.02	2.09
Earnings From Equity Investments	0.4	0.17	-1.63	-3.77	-5.53
Currency Exchange Gain (Loss)	0.3	-0.1	0.36	0.05	-1.58
EBT Excluding Unusual Items	408.89	260.44	224.47	222.08	129.17
Gain (Loss) on Sale of Investments	-0.84	1.62	-	3.3	7.46
Gain (Loss) on Sale of Assets	-4.1	-0.05	-3.42	0.25	1.07
Asset Writedown	-30.32	-7.43	-	5.55	0.49
Other Unusual Items	-	-	29.3	0.25	82.39
Pretax Income	373.63	254.58	250.35	231.43	220.57
Income Tax Expense	72.79	44.41	42.98	43.73	34.26
Earnings From Continuing Operations	300.83	210.17	207.37	187.71	186.31
Earnings From Discontinued Operations	-	80.61	75.84	-	0
Net Income to Company	300.83	290.78	283.21	187.71	186.31
Minority Interest in Earnings	-	-23.81	-32.17	-10.04	-12.6
Net Income	300.83	266.97	251.04	177.67	173.71
Net Income to Common	300.83	266.97	251.04	177.67	173.71
Net Income Growth	12.68%	6.34%	41.30%	2.28%	-19.44%
Shares Outstanding (Basic)	1,986	1,920	1,911	1,916	1,916
Shares Outstanding (Diluted)	1,986	1,920	1,912	1,916	1,916
Shares Change (YoY)	3.42%	0.45%	-0.21%	-0.03%	-3.37%
EPS (Basic)	0.15	0.14	0.13	0.09	0.09
EPS (Diluted)	0.15	0.14	0.13	0.09	0.09
EPS Growth	8.96%	5.89%	41.57%	2.30%	-16.63%
Free Cash Flow	278.39	354.85	567.09	343.08	345.9
Free Cash Flow Per Share	0.14	0.18	0.30	0.18	0.18
Dividend Per Share	0.090	0.055	0.052	0.039	0.023
Dividend Growth	63.64%	6.18%	33.51%	68.70%	-48.89%
Gross Margin	43.94%	42.27%	42.52%	38.89%	38.80%
Operating Margin	27.45%	21.22%	21.24%	15.57%	11.37%
Profit Margin	19.08%	18.19%	19.80%	11.13%	12.01%
Free Cash Flow Margin	17.66%	24.18%	44.74%	21.50%	23.92%
EBITDA	541.86	415.94	380.38	391.76	299.89
EBITDA Margin	34.36%	28.34%	30.01%	24.55%	20.74%
D&A For EBITDA	108.99	104.53	111.12	143.29	135.57
EBIT	432.87	311.4	269.27	248.47	164.33
EBIT Margin	27.45%	21.22%	21.24%	15.57%	11.37%
Effective Tax Rate	19.48%	17.45%	17.17%	18.89%	15.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.